Keyphrases
Alpha-synuclein (α-syn)
100%
Parkinson's Disease
84%
Dopamine
37%
Caenorhabditis Elegans
32%
Prion-like
25%
Neurodegeneration
23%
Neurodegenerative Diseases
19%
Behavioral Screen
18%
High-throughput
16%
Parkinson Patients
12%
Hippocampus
12%
Neural Progenitors
12%
Adaptive Response
12%
Normal Brain
12%
Hyperactivity
12%
Filamentous Actin (F-actin)
12%
Embryonic Stem Cells
12%
Cross-omics Analysis
12%
Parkinson
12%
Nigrostriatal Degeneration
12%
Parkinson's Disease Model
12%
Heparan Sulfate Proteoglycans
12%
Network Approach
12%
Profilin
12%
Putative Drug Targets
12%
Human Brain
12%
Gut-brain Axis
12%
Chemokine Ligand 12 (CXCL12)
12%
In Vivo Model
12%
Microtubules
12%
Stem Cell-derived
12%
Structural Flexibility
12%
Human Disease Genes
12%
Phosphorylation
12%
Neuronal Activity
12%
Drug Candidates
12%
Substantia Nigra
10%
Mitochondrial Function
10%
Actin
9%
Disease Mechanisms
9%
Dopamine Level
9%
Spasm
8%
Branched-chain Aminotransferase
8%
Dopaminergic Neurons
7%
Enteric Nervous System
7%
Galaxies
7%
Cholinergic Neurons
7%
Dentate Gyrus
7%
Elegans
6%
Human Genome
6%
Neuroscience
Synuclein
87%
Parkinson's Disease
73%
Prion
25%
Neurodegeneration
20%
Oligomer
18%
In Vivo
13%
Hippocampus
12%
Actin
12%
Adaptive Response
12%
Proteoheparan Sulfate
12%
Embryonic Stem Cell
12%
Hyperactivity
12%
Profilin
12%
Microtubule
12%
Serine
12%
Cholinergic
12%
Alpha-Synuclein
12%
Neuronal Activity
12%
Neurodegenerative Disorder
11%
Substantia nigra
10%
Stereotypic Movement Disorder
8%
Dopaminergic
8%
Dentate Gyrus
7%
Lewy Body
6%
Caenorhabditis Elegans
6%
Branched-Chain Amino Acid
5%
Neural Network
5%
Biochemistry, Genetics and Molecular Biology
Synuclein
87%
Caenorhabditis Elegans
36%
Amino Acid Metabolism
15%
Heparan Sulfate
12%
Cholinergic
12%
Homeostasis
12%
Neuronal Activity
12%
Candidate Gene
12%
Body Position
12%
Serine
12%
Prion
12%
Proteoglycan
12%
Alpha-Synuclein
12%
Dopaminergic
11%
Conformation
11%
Transferase
10%
Amino Acids
10%
Mouse
9%
RNA Interference
7%
Cholinergic Neuron
5%
Metabolite
5%